Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Point-of-Care or Rapid Testing Market by Type (Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Urinalysis Testing, Others), By Application (Clinics, Hospitals, Laboratory, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Point-of-Care or Rapid Testing Market by Type (Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Urinalysis Testing, Others), By Application (Clinics, Hospitals, Laboratory, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 263690 4200 Medical Devices & Consumables 377 225 Pages 4.5 (48)
                                          

Industry Growth Insights published a new data on “Point-of-Care or Rapid Testing Market”. The research report is titled “Point-of-Care or Rapid Testing Market research by Types (Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Urinalysis Testing, Others), By Applications (Clinics, Hospitals, Laboratory, Others), By Players/Companies Roche, Abbott, Johnson & Johnson, Siemens Healthcare, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux, ARKRAY, Nova Biomedical, Roche, Quidel, Accriva, OraSure Technologies, Helena Laboratories, A. Menarini Diagnostics, Abaxis (Zoetis), Ortho Clinical Diagnostics, Phamatech, Chembio Diagnostics, Sinocare, Wondfo, Yuwell, Runbio, KHB, Wuhan EasyDiagnosis Biomedicine, DAAN GENE”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Point-of-Care or Rapid Testing Market Research Report

By Type

Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Urinalysis Testing, Others

By Application

Clinics, Hospitals, Laboratory, Others

By Companies

Roche, Abbott, Johnson & Johnson, Siemens Healthcare, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux, ARKRAY, Nova Biomedical, Roche, Quidel, Accriva, OraSure Technologies, Helena Laboratories, A. Menarini Diagnostics, Abaxis (Zoetis), Ortho Clinical Diagnostics, Phamatech, Chembio Diagnostics, Sinocare, Wondfo, Yuwell, Runbio, KHB, Wuhan EasyDiagnosis Biomedicine, DAAN GENE

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

225

Number of Tables & Figures

158

Customization Available

Yes, the report can be customized as per your need.


Global Point-of-Care or Rapid Testing Industry Outlook


Global Point-of-Care or Rapid Testing Market Report Segments:

The global Point-of-Care or Rapid Testing market is segmented on the basis of:

Types

Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Urinalysis Testing, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Clinics, Hospitals, Laboratory, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Roche
  2. Abbott
  3. Johnson & Johnson
  4. Siemens Healthcare
  5. Danaher
  6. Ascensia
  7. Bio-Rad Laboratories
  8. BioMerieux
  9. ARKRAY
  10. Nova Biomedical
  11. Roche
  12. Quidel
  13. Accriva
  14. OraSure Technologies
  15. Helena Laboratories
  16. A. Menarini Diagnostics
  17. Abaxis (Zoetis)
  18. Ortho Clinical Diagnostics
  19. Phamatech
  20. Chembio Diagnostics
  21. Sinocare
  22. Wondfo
  23. Yuwell
  24. Runbio
  25. KHB
  26. Wuhan EasyDiagnosis Biomedicine
  27. DAAN GENE

Global Point-of-Care or Rapid Testing Market Overview


Highlights of The Point-of-Care or Rapid Testing Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Blood Glucose Testing
    2. Infectious Diseases Testing
    3. Cardiac Markers Testing
    4. Coagulation Testing
    5. Pregnancy and Fertility Testing
    6. Blood Gas/Electrolytes Testing
    7. Urinalysis Testing
    8. Others
  1. By Application:

    1. Clinics
    2. Hospitals
    3. Laboratory
    4. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Point-of-Care or Rapid Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Point-of-Care or Rapid Testing Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Point-of-care or rapid testing is a diagnostic test that can be performed onsite by a healthcare professional. This type of testing is often used to diagnose diseases and conditions quickly and easily.

Some of the major players in the point-of-care or rapid testing market are Roche, Abbott, Johnson & Johnson, Siemens Healthcare, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux, ARKRAY, Nova Biomedical, Roche, Quidel, Accriva, OraSure Technologies, Helena Laboratories, A. Menarini Diagnostics, Abaxis (Zoetis), Ortho Clinical Diagnostics, Phamatech, Chembio Diagnostics, Sinocare, Wondfo, Yuwell, Runbio, KHB, Wuhan EasyDiagnosis Biomedicine, DAAN GENE.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Point-of-Care or Rapid Testing Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Point-of-Care or Rapid Testing Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Point-of-Care or Rapid Testing Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Point-of-Care or Rapid Testing Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Point-of-Care or Rapid Testing Market Size & Forecast, 2018-2028       4.5.1 Point-of-Care or Rapid Testing Market Size and Y-o-Y Growth       4.5.2 Point-of-Care or Rapid Testing Market Absolute $ Opportunity

Chapter 5 Global Point-of-Care or Rapid Testing Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Point-of-Care or Rapid Testing Market Size Forecast by Type
      5.2.1 Blood Glucose Testing
      5.2.2 Infectious Diseases Testing
      5.2.3 Cardiac Markers Testing
      5.2.4 Coagulation Testing
      5.2.5 Pregnancy and Fertility Testing
      5.2.6 Blood Gas/Electrolytes Testing
      5.2.7 Urinalysis Testing
      5.2.8 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Point-of-Care or Rapid Testing Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Point-of-Care or Rapid Testing Market Size Forecast by Applications
      6.2.1 Clinics
      6.2.2 Hospitals
      6.2.3 Laboratory
      6.2.4 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Point-of-Care or Rapid Testing Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Point-of-Care or Rapid Testing Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Point-of-Care or Rapid Testing Analysis and Forecast
   9.1 Introduction
   9.2 North America Point-of-Care or Rapid Testing Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Point-of-Care or Rapid Testing Market Size Forecast by Type
      9.6.1 Blood Glucose Testing
      9.6.2 Infectious Diseases Testing
      9.6.3 Cardiac Markers Testing
      9.6.4 Coagulation Testing
      9.6.5 Pregnancy and Fertility Testing
      9.6.6 Blood Gas/Electrolytes Testing
      9.6.7 Urinalysis Testing
      9.6.8 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Point-of-Care or Rapid Testing Market Size Forecast by Applications
      9.10.1 Clinics
      9.10.2 Hospitals
      9.10.3 Laboratory
      9.10.4 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Point-of-Care or Rapid Testing Analysis and Forecast
   10.1 Introduction
   10.2 Europe Point-of-Care or Rapid Testing Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Point-of-Care or Rapid Testing Market Size Forecast by Type
      10.6.1 Blood Glucose Testing
      10.6.2 Infectious Diseases Testing
      10.6.3 Cardiac Markers Testing
      10.6.4 Coagulation Testing
      10.6.5 Pregnancy and Fertility Testing
      10.6.6 Blood Gas/Electrolytes Testing
      10.6.7 Urinalysis Testing
      10.6.8 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Point-of-Care or Rapid Testing Market Size Forecast by Applications
      10.10.1 Clinics
      10.10.2 Hospitals
      10.10.3 Laboratory
      10.10.4 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Point-of-Care or Rapid Testing Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Point-of-Care or Rapid Testing Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Point-of-Care or Rapid Testing Market Size Forecast by Type
      11.6.1 Blood Glucose Testing
      11.6.2 Infectious Diseases Testing
      11.6.3 Cardiac Markers Testing
      11.6.4 Coagulation Testing
      11.6.5 Pregnancy and Fertility Testing
      11.6.6 Blood Gas/Electrolytes Testing
      11.6.7 Urinalysis Testing
      11.6.8 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Point-of-Care or Rapid Testing Market Size Forecast by Applications
      11.10.1 Clinics
      11.10.2 Hospitals
      11.10.3 Laboratory
      11.10.4 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Point-of-Care or Rapid Testing Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Point-of-Care or Rapid Testing Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Point-of-Care or Rapid Testing Market Size Forecast by Type
      12.6.1 Blood Glucose Testing
      12.6.2 Infectious Diseases Testing
      12.6.3 Cardiac Markers Testing
      12.6.4 Coagulation Testing
      12.6.5 Pregnancy and Fertility Testing
      12.6.6 Blood Gas/Electrolytes Testing
      12.6.7 Urinalysis Testing
      12.6.8 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Point-of-Care or Rapid Testing Market Size Forecast by Applications
      12.10.1 Clinics
      12.10.2 Hospitals
      12.10.3 Laboratory
      12.10.4 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Point-of-Care or Rapid Testing Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Point-of-Care or Rapid Testing Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Point-of-Care or Rapid Testing Market Size Forecast by Type
      13.6.1 Blood Glucose Testing
      13.6.2 Infectious Diseases Testing
      13.6.3 Cardiac Markers Testing
      13.6.4 Coagulation Testing
      13.6.5 Pregnancy and Fertility Testing
      13.6.6 Blood Gas/Electrolytes Testing
      13.6.7 Urinalysis Testing
      13.6.8 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Point-of-Care or Rapid Testing Market Size Forecast by Applications
      13.10.1 Clinics
      13.10.2 Hospitals
      13.10.3 Laboratory
      13.10.4 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Point-of-Care or Rapid Testing Market: Competitive Dashboard
   14.2 Global Point-of-Care or Rapid Testing Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Roche
      14.3.2 Abbott
      14.3.3 Johnson & Johnson
      14.3.4 Siemens Healthcare
      14.3.5 Danaher
      14.3.6 Ascensia
      14.3.7 Bio-Rad Laboratories
      14.3.8 BioMerieux
      14.3.9 ARKRAY
      14.3.10 Nova Biomedical
      14.3.11 Roche
      14.3.12 Quidel
      14.3.13 Accriva
      14.3.14 OraSure Technologies
      14.3.15 Helena Laboratories
      14.3.16 A. Menarini Diagnostics
      14.3.17 Abaxis (Zoetis)
      14.3.18 Ortho Clinical Diagnostics
      14.3.19 Phamatech
      14.3.20 Chembio Diagnostics
      14.3.21 Sinocare
      14.3.22 Wondfo
      14.3.23 Yuwell
      14.3.24 Runbio
      14.3.25 KHB
      14.3.26 Wuhan EasyDiagnosis Biomedicine
      14.3.27 DAAN GENE

Our Trusted Clients

Contact Us